Celesia, Benedetto Maurizio, et al. “IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS µL?”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 11, no. 1, Oct. 2019, p. e2019063, doi:10.4084/mjhid.2019.063.